486 results on '"Mactutus Charles F"'
Search Results
2. Adolescent oral oxycodone self-administration disrupts neurobehavioral and neurocognitive development
3. SARS-CoV-2 RNA persists in the central nervous system of non-human primates despite clinical recovery
4. Microglia proliferation underlies synaptic dysfunction in the prefrontal cortex: implications for the pathogenesis of HIV-1-associated neurocognitive and affective alterations
5. Endogenous amyloidogenesis in long-term rat hippocampal cell cultures
6. Prenatal cocaine exposure alters alpha2 receptor expression in adolescent rats
7. Gonadal steroids differentially modulate neurotoxicity of HIV and cocaine: testosterone and ICI 182,780 sensitive mechanism
8. Therapeutically targeting the consequences of HIV-1-associated gastrointestinal dysbiosis: Implications for neurocognitive and affective alterations
9. Chronic SSRI treatment reverses HIV-1 protein-mediated synaptodendritic damage
10. HIV Infection and Neurocognitive Disorders in the Context of Chronic Drug Abuse: Evidence for Divergent Findings Dependent upon Prior Drug History
11. S-Equol mitigates motivational deficits and dysregulation associated with HIV-1
12. S-EQUOL: a neuroprotective therapeutic for chronic neurocognitive impairments in pediatric HIV
13. Selective Estrogen Receptor β Agonists: a Therapeutic Approach for HIV-1 Associated Neurocognitive Disorders
14. HIV-1 mRNA Knockdown with CRISPR/Cas9 Enhances Neurocognitive Function
15. Diagnostic and prognostic biomarkers for HAND
16. Selective monoaminergic and histaminergic circuit dysregulation following long-term HIV-1 protein exposure
17. SARS-CoV-2 RNA Persists in the Central Nervous System of Non-Human Primates Despite Clinical Recovery
18. Constitutive expression of HIV-1 viral proteins induces progressive synaptodendritic alterations in medium spiny neurons: implications for substance use disorders
19. Evolution of the HIV-1 transgenic rat: utility in assessing the progression of HIV-1-associated neurocognitive disorders
20. Microglia Proliferation Underlies Synaptic Dysfunction in the Prefrontal Cortex: Implications for the Pathogenesis of HIV-1-Associated Neurocognitive and Affective Alterations
21. Correction to: HIV Infection and Neurocognitive Disorders in the Context of Chronic Drug Abuse: Evidence for Divergent Findings Dependent upon Prior Drug History
22. A Gap in Time: Extending our Knowledge of Temporal Processing Deficits in the HIV-1 Transgenic Rat
23. Selective developmental alterations in The HIV-1 transgenic rat: Opportunities for diagnosis of pediatric HIV-1
24. Synaptic dysfunction is associated with alterations in the initiation of goal-directed behaviors: Implications for HIV-1-associated apathy
25. HIV-1 proteins dysregulate motivational processes and dopamine circuitry
26. Disrupted Decision-Making: EcoHIV Inoculation in Cocaine Dependent Rats
27. Intraneuronal β-Amyloid Accumulation: Aging HIV-1 Human and HIV-1 Transgenic Rat Brain
28. Motivational Dysregulation with Melanocortin 4 Receptor Haploinsufficiency
29. HIV-1 Tat protein variants: Critical role for the cysteine region in synaptodendritic injury
30. Disrupted Decision-Making: EcoHIV Inoculation Following a History of Cocaine Use
31. HIV-1 Transgenic Female Rat: Synaptodendritic Alterations of Medium Spiny Neurons in the Nucleus Accumbens
32. Modeling Deficits in Attention, Inhibition, and Flexibility in HAND
33. Neurodevelopmental Processes in the Prefrontal Cortex Derailed by Chronic HIV-1 Viral Protein Exposure
34. SYNAPTIC DYSFUNCTION UNDERLIES ALTERATIONS IN THE INITIATION OF GOAL-DIRECTED BEHAVIORS: IMPLICATIONS FOR HIV-1 ASSOCIATED APATHY
35. Neurodevelopmental processes in the prefrontal cortex derailed by chronic HIV-1 viral protein exposure
36. Neuronal survival and resistance to HIV-1 Tat toxicity in the primary culture of rat fetal neurons
37. Time and Time Again: Temporal Processing Demands Implicate Perceptual and Gating Deficits in the HIV-1 Transgenic Rat
38. HIV-Associated Apathy/Depression and Neurocognitive Impairments Reflect Persistent Dopamine Deficits
39. Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: Current status of dopamine system vulnerability in NeuroAIDS
40. Different effects of selective dopamine uptake inhibitors, GBR 12909 and WIN 35428, on HIV-1 Tat toxicity in rat fetal midbrain neurons
41. Evidence for developmental dopaminergic alterations in the human immunodeficiency virus-1 transgenic rat
42. Synaptodendritic recovery following HIV Tat exposure: Neurorestoration by phytoestrogens
43. Microglial HIV-1 Expression: Role in HIV-1 Associated Neurocognitive Disorders
44. Dopaminergic marker proteins in the substantia nigra of human immunodeficiency virus type 1-infected brains
45. Animal Models: Behavior and Pathology: Preclinical Assessment of the Putative Cognitive Deficits in HAND
46. Neurotoxicity of HIV-1 Tat protein: Involvement of D1 dopamine receptor
47. Neonatal intrahippocampal gp120 injection: An examination early in development
48. A Rat Model of EcoHIV Brain Infection
49. Chronic SSRI treatment reverses HIV-1 protein-mediated synaptodendritic damage
50. HIV-1-induced apathy: Mitigation by the gut metabolite, S-Equol
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.